Boston Scientific Launches AVVIGO™+ Multi-Modality Guidance System in India
In line with its mission to transform the lives of patients around the world through innovative medical solutions, Boston Scientific Corporation (NYSE: BSX) today announced the launch of AVVIGO™+ Multi-Modality Guidance System, a next-generation intravascular ultrasound (IVUS) and fractional flow reserve (FFR)…
MedStar Washington Hospital Center Ranks Among Nation’s Best Hospitals and Shares the #1 Spot in the Washington Region
MedStar Washington Hospital Center shares its status as the No. 1 hospital in the Washington Metro area in the newly released 2024-2025 U.S. News & World Report’s Best Hospitals. Additionally, two of MedStar Washington’s clinical programs are nationally ranked. Cardiology, Heart &…
At the SIRM Congress 2024 in Milan, ESAOTE presents the brand-new MyLab™E80, an E-series ultrasound device designed for professionals dealing with more complex clinical cases
Esaote – a leading Italian company in the field of medical imaging – has unveiled its new MyLab™E80 ultrasound device to the world of radiology. The unveiling took place at the 51st SIRM Congress 2024 (Allianz MiCo Convention Center, Milan – Stand I-03), the first time the three scientific societies…
Revolutionize Your Period Routine: Discover the Ultimate Comfort and Sustainability with Top 4 Reusable Pads
Embark on a transformative journey towards eco-conscious period care with the top 4 reusable pads that redefine comfort, sustainability, and confidence. Let’s delve deeper into the unique features and benefits of each brand: 1. Revaa Reusable Pads: Imagine experiencing hassle-free…
Mansathali Intervenes to Rescue Child from Social Media Addiction
Today, the whole world is dominated by digital technology; it doesn’t matter what your age or gender is, you are tech addicted. Concerns about the impact of social media addiction on children’s well-being have become more pressing than ever. However,…
Neurocrine Biosciences Announces First-Patient Dosed in Phase 2 Clinical Study Evaluating NBI-1070770 in Adults with Major Depressive Disorder
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the first patient has been randomized for its Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder. NBI-1070770 is a novel,…
Moon Surgical Expands to Gynecological Surgery
The Franche-Comté Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, today announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures. Over the past few weeks,…
Amazon Spring Sale 2024: Save 15% to 40% on Jackery Mini Power Stations, Solar Generators, and More
Just in time for the start of the outdoor season, Jackery is offering deep discounts on selected power stations and solar generators via Amazon. Suitable for canny savers and Easter Bunnies alike, the high-quality portable power solutions are available at heavily discounted…
The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China
Co-hosted by the Nanyang Chinese Medicine Development Bureau, the China Association of Chinese Medicine (CACM) and the China Association of Traditional Chinese Medicine (CATCM), the Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM was held in Nanyang, China from February…
Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
The Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research worldwide, welcomes the U.S. Food and Drug Administration (FDA) decision to approve Iovance Biotherapeutics’ AMTAGVI™ (lifileucel) for the treatment of patients with advanced melanoma in the second line treatment setting….
